Product and process validation for cold chain free, live attenuated cholera vaccine

Chan Yean, Yean (2018) Product and process validation for cold chain free, live attenuated cholera vaccine. (Submitted)

Download (423kB) | Preview


A Fed- batch fermentauon prc.cess was standardized for high cell density culu~ation of th~ al!onuated choltJra Vaccinc candidate (VCUSM14P). The f£:d·batch operation resulted In the highest cell densuy of 1.81) g cells ill. The concentrated bionta!.s was used to formulate 480 vials of l•quid attenuated ~aCC'ne containing (6 x 10A8 CFU I ml). The storage stability of the vaccine formulation was evilluatdd for 1ts punty. potency and v1ab1hly by phenotypic and genotyPI•: mo;thO':ls over an el(!ended storage period of 140 days al25'C i 2 ·c and 60% 15% rela!Jve humidity on the BonctPr ICH compliant Stab•hty Chamber The viability of lhe vaccme strain (VCUSM14Pj m the fomwlat1on after 140 days of storage was recorded Cilh 6 x 10'6 CFU iml which iS 2tog~ iowei as compared to its storage at room temperature (25 • C :t 2"Cj •e; 6 x 10·'8 CFU lml and the reouct1on of CFUs might be allrobuted to the hogh humid.ty To ascerta·n the genet;c punty of VCUSM14P culture 1n the formulation. the PCR was conducted by usmg lwo dtfferent pnmer sets. The results indicate that the VCUSM14P strain~~ •nlact and comparable to the positive control VCUSM14P (unformulated) Thn vacicie cut·ure purity was validated by series of b•ochc>mical tests that are specific for Vibno cholera e. S1nce colomzalion IS critical for eliCitation of the immune response. the VCUSM i4P formulation was examined for thei coloniza!JO!lln I he 1nfant mouse model. The colonization ablhty of formulated VCUSM14 shall\ wa& good and recordod with two logs h1gher than thai of onfonnulated VCUSM14P stram ll eftec!lvely colonized and Induced a higher titer of antibodies. In order to assess whelher the vaccine fonmlla!lon Is caus•nn reactoqen•u•y, stud•es wr>re perfomtt>d "' hg;ue..i ~e.11 hlops of unvar:cm<>t<'!o rat>llil> anrt ,JnillyZP.d for the flUid accumulauon 1n cum;>.mson with ·:.old tyJ.oe and untormul;;ted VCUSM1.1P lt•e vacc•··n formulat•on was found to be non-react09enoc nt dos•J, o' 11)'5·10'6 in rabbi! Ileal loop model. The protectM! eff1cacy of vacane formulatiOn WilS delermtned by challeng•J19 .mml.ln•zed ri>hbits b)' the RevPrs•t>te lnlesllna• Tte ArJull Rabb•t Diarrhoea (RITARD) model. Rabt•rts ··acc1nat~ c~•th v<J•Xi!'10 fonnl•lallon C>l' untorl'lul<oted VCUSM :4P s•Jrvlved the chall~nge and sho;·.oJ no ~•gns or charrhoe<o and other symptoms of disease or death up lo 5 days of tha observatiOn period. Wher«>as. 100% n10rtal•ly obse•ved In un,•accinated (control! r<lbb•ts ·Mfhln 18 hours post challenge l'.ilh wild lype. In conclusion. our results validate the cold chain free formulatJon of VC.:USM11P IS non-re<Jctogcn•c and •mmunogemc in vivo. and protects animals from lethal V. choleran 01~19 challenge. A Palen! for "A monovalent vaccme formula~on and a meihorl for preparai!Onlhereor was filifJd on 09/01;2018. Reference. Palen! Applicallon No Pl2018700106 at Intellectual Property Corporabon of Malaysia tMyiPO

Item Type: Article
Uncontrolled Keywords: Vaccinc
Subjects: R Medicine > R Medicine (General)
Divisions: Kampus Kesihatan (Health Campus) > Pusat Pengajian Sains Perubatan (School of Medical Sciences) > Thesis
Depositing User: Mr Husnan Budin
Date Deposited: 13 Mar 2022 03:41
Last Modified: 13 Mar 2022 07:27

Actions (login required)

View Item View Item